BriaCell Files Provisional Patent Application for Novel Treatment and Diagnosis of Coronavirus Disease

    NEXT STORY
    Mateon is Selected by IBM Watson Health for the Use of IBM Clinical Development Solution at No Cost for Phase II Clinical Trial of OT-101 for COVID-19
    PREV STORY
    Global medical supplies market to record 13.5% CAGR through 2026
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ascendis Pharma A/S Reports Full Year 2018 Financial Results

    author_avatar
    NASDAQ Market News

    Enzymatica AB: Completing the Nomination Committee’s in Enzymatica AB proposal for AGM 2017 regarding election of auditor

    Press ReleaseLund April 5, 2017                                                                                     Completing the Nomination Committee's in Enzymatica AB proposal ...

    author_avatar
    NASDAQ Market News

    Intercept Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

    Worldwide net Ocaliva® (obeticholic acid or OCA) 3Q 2017 sales of $40.9 million (including ...

    author_avatar
    NASDAQ Market News